Sequential administration of sialic acid-modified liposomes as carriers for epirubicin and zoledronate elicit stronger antitumor effects with reduced toxicity.
暂无分享,去创建一个
Xinrong Liu | Yanzhi Song | Yihui Deng | Xueying Tang | Junqiang Ding | Ning Zhang | Ying Qin | Dezhi Sui | Yang Wang